We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · April 29, 2015

Repeat Positron Emission Tomography Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma

JAMA Surgery

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Surgery
Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma
JAMA Surg 2015 Apr 22;[EPub Ahead of Print], M Kukar, RM Alnaji, F Jabi, TA Platz, K Attwood, H Nava, K Ben-David, D Mattson, K Salerno, U Malhotra, K Kanehira, J Gannon, SN Hochwald

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading